Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B 1.1.7 variant of SARS-CoV-2
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Travel Medicine"
DOI: 10.1093/jtm/taab051
Abstract: Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2 Gajanan N. Sapkal, PhD1, Pragya D. Yadav, PhD1,*, Raches Ella, MS2, Gururaj R. Deshpande, PhD1, Rima R. Sahay, MD1, Nivedita Gupta, PhD3, Krishna… read more here.
Keywords: vaccine bbv152; inactivated covid; bbv152 covaxin; covid vaccine ... See more keywords
Booster dose of the inactivated COVID-19 vaccine BBV152 (Covaxin) enhances the neutralizing antibody response against alpha, Beta, Delta and omicron variants of concern.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of travel medicine"
DOI: 10.1093/jtm/taac039
Abstract: The neutralizing antibody responses were significantly elevated after 3rd dose of BBV152/Covaxin against the B.1 (19.11 fold)variant including Delta (16.51 fold), Beta (14.70 fold) and Omicron (18.53 fold) Variants of concern in comparison with two… read more here.
Keywords: bbv152 covaxin; neutralizing antibody; variants concern;